This is a preview of subscription content, log in via an institution to check access.
Notes
Norwegian kroner
Reference
Brkic A, et al. Drug Cost for Biologic and Targeted Synthetic Dmards for Rheumatoid Arthritis Patients in Norway from 2010 to 2019 - a Country with a National Tender System for Drug Prescription. 22nd Annual Congress of the European League Against Rheumatism : abstr. OP0238, 2 Jun 2021. Available from: URL: http://scientific.sparx-ip.net/archiveeular/index.cfm?view=2&c=a&item=2021OP0238
Rights and permissions
About this article
Cite this article
Costs of treating RA reducing in Norway due to national annual tender process. PharmacoEcon Outcomes News 882, 6 (2021). https://doi.org/10.1007/s40274-021-7840-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7840-7